A diagnostic enigma – the issue without the right tissue. (#8)
CO, a 52-year-old woman presented to hospital with two years history of intermittent headache, polydipsia, polyuria, amenorrhea, weight gain and a pruritic nodular rash. She had a background of Type 2 diabetes and a recent diagnosis of primary sclerosing cholangitis. A MRI brain organised by the GP revealed a left hypothalamus large ill-defined nodular lesion, extending along the left lateral wall of the third ventricle and into the caudate nucleus. The pituitary gland and infundibulum otherwise were reported to be normal. The patient was reviewed by Neurosurgery and deemed unsuitable for brain biopsy due to the high risk of developing hemiplegia. She was subsequently investigated by Endocrinology for her polyuria and polydipsia.
Inpatient water deprivation test confirmed central diabetes insipidus and she was commenced on desmopressin with good effect. Baseline pituitary panel performed demonstrated an elevated prolactin level: 1270mIU/L [RR: 110-560mIU/L] and hypogonadotropic hypogonadism (LH 0.1 IU/L and FSH 2.2 IU/L). The patient was also noted to have a PTH independent hypercalcaemia (cCa 2.85mmol/L, PTH 2.8mmol/L) raising the suspicion of an underlying malignant process. Extensive work up was then conducted. This included lumbar puncture which revealed mixed inflammation (glucose of 5.7g/L, total protein of 0.96g/L), but negative oligoclonal bands, culture and flow cytometry. Serum flow cytometry detected minor population (2%) of CD4 / CD8 co-expressing T cells although non-specific as per haematology review. The 1,25-Vitamin D level was elevated (159pmol/L [RR: 35-120pmol/L]) but serum ACE level was normal. Multiple skin biopsies were also performed of the nodular skin lesions, but returned negative for sarcoidosis, histiocytosis and lymphoma. Whole-body CT scan was unremarkable. FDG-PET scan was finally performed, with increased uptake detected in the left hypothalamus, right sacrum and posterior L2 spinous process. The pituitary gland did not have increased avidity. CO was discharged with ongoing outpatient investigation and active surveillance…
- 1. Gul OO, Sisman P et al An unusual case of adult-onset multi-systemic Langerhans cell histiocytosis with perianal and incident thyroid involvement. Endocrinol Diabetes Metab Case Rep. 2017 Feb 2;2017:16-0087. doi: 10.1530/EDM-16-0087. PMID: 28458889; PMCID: PMC5404461.
- 2. Patten DK, Wani Z, Tolley N. 2012. Solitary langerhans histiocytosis of the thyroid gland: a case report and literature review. Head and Neck Pathology 6 279–289. ( 10.1007/s12105-011-0321-8)
- 3. Shevale VV, Ekta K et al 2014. A rare occurrence of Langerhans cell histiocytosis in an adult. Journal of Oral and Maxillofacial Pathology 18 415–419.
- 4. Girschikofsky M, Arico M et al. Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis. 2013 May 14;8:72. doi: 10.1186/1750-1172-8-72. PMID: 23672541; PMCID: PMC3667012.
- 5. Tran G, Huynh TN, Paller AS. Langerhans cell histiocytosis: A neoplastic disorder driven by Ras-ERK pathway mutations. J Am Acad Dermatol. 2018 Mar;78(3):579-590.e4. doi: 10.1016/j.jaad.2017.09.022. Epub 2017 Oct 26. PMID: 29107340.
- 6. Hatemi I, Baysal B. Adult Langerhans cell histiocytosis and sclerosing cholangitis: A case report and review of literature. Hepatol Int. 2010;4(3):653. EPub 2010 Aug 4.
- 7. Fahrner B, Prosch H et al. Longer-term outcomes of hypothalamic pituitary tumours in Langerhans cell histiocytosis. Pediatric Blood Cancer. 2012 April; 58(4):606 -10.Epub 2011 Dec 19.
- 8. Al-Ali H, Yabis AA, Issa E, Salem Z, Tawil A, Khoury N, Fuleihan Gel-H. Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level. Bone. 2002 Jan;30(1):331-4. doi: 10.1016/s8756-3282(01)00651-2. PMID: 11792606.
- 9. Cantu MA. Optimal therapy for adults with Langerhans cell histiocytosis bone lesions. PLoS One. 2012;7(8):e43257
- Chakraborty R, Burke TM, Hampton OA, Zinn DJ, Lim KP, Abhyankar H, Scull B, Kumar V, Kakkar N, Wheeler DA, Roy A, Poulikakos PI, Merad M, McClain KL, Parsons DW, Allen CE. Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis. Blood. 2016;128:2533–2537.